Pharmacokinetics and relative bioavailability of probucol inclusion complex capsule in healthy dogs

Yaoxue Xuebao

Volumn 37, Issue 3, 2002, Pages 210-213

  Zhang, Zheng ^a   Chen, Bao Ling ^a   Wang, Ke ^b   Huang, Yi Ling ^c   Fang, Shu Qing ^d   Gu, De Liang ^a   Fang, Li ^a   Han, Shao Jun ^a  

^a FUWAI HOSPITAL   (China)

^b INSTITUTE OF MATERIA MEDICA   (China)

^c PEKING UNION MEDICAL COLLEGE   (China)

^d Puning Pharmaceutical Factory   (China)

Author keywords

HPLC; Pharmacokinetics; Probucol; Relative bioavailability

Indexed keywords

HYPOCHOLESTEROLEMIC AGENT; PROBUCOL;

ANIMAL; ARTICLE; BIOAVAILABILITY; COMPARATIVE STUDY; DOG; FEMALE; MICROCAPSULE; ORAL DRUG ADMINISTRATION; RANDOMIZATION; TABLET;

ADMINISTRATION, ORAL; ANIMALS; ANTICHOLESTEREMIC AGENTS; BIOLOGICAL AVAILABILITY; CAPSULES; DOGS; FEMALE; PROBUCOL; RANDOM ALLOCATION; TABLETS;

EID: 0042737673     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Barnhart JW, Sefranka JA, McIntosh DD. Hypocholesterolemic effect of 4, 4′-(isopropylidenedithio)-bis (2, 6-di-t-butylpheno) (probucol) [J]. Am J Clin Nutr, 1970,23(9): 1229-1233.
2. Heel RC, Brogden RN, Speight TM, et al. Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolemia [J]. Drugs, 1978, 15 (6):409-428.
3. Buckley MM, Goa KL, Price AH, et al. Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolemia [J]. Drugs, 1989,37(6):761 -780.
4. Schwartz CJ. Introduction - the probucol experience: a review of the past and a look at the future [J]. Am J Cardiol, 1988,62(3):1B-5B.
5. Matsuzawa Y, Yamashita S, Funahashi T, et al. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyper HDL2 cholesterolemia with abnormal cholesteryl ester transfer [J]. Am J Cardiol, 1988,62(3):66B-72B.
6. Schneider JE, Berk BC, Gravanis MB, et al. Probucol decreases neointimal formation in a swine model of coronary artery balloon injury [J]. Circulation, 1993,88(2):628-637.
7. Kudo S, Akiyama H, Odomi M, et al. High-performance liquid Chromatographic procedure for the determination of probucol in human plasma [J]. J Chromatogr, 1983,277 (2):419-422.
8. Jaffar NZ, Nitin KG, Louise AF, et al. Measurement of plasma probucol levels by high-performance liquid chromatography [J]. J Chromatogr Biomed, 1994,654(1): 55-60.
9. Huang SK, Han KQ. Several statistical approaches to bioequivalence assessement [J]. Chin J Clin Pharmacol (41 gltößtcl535fe;E), 1993,9(1):43-46.